In a proof-of-principle study in mice, scientists at Johns Hopkins Medicine report the creation of a specialized gel that acts like a lymph node to successfully activate and multiply cancer-fighting immune system T-cells. The work puts scientists a step closer, they say, to injecting such artificial lymph nodes into people and sparking T-cells to fight disease.
In the past few years, a wave of discoveries has advanced new techniques to use T-cells — a type of white blood cell — in cancer treatment. To be successful, the cells must be primed, or taught, to spot and react to molecular flags that dot the surfaces of cancer cells. The job of educating T-cells this way typically happens in lymph nodes, small, bean-shaped glands found all over the body that house T-cells. But in patients with cancer and immune system disorders, that learning process is faulty, or doesn’t happen.
To address such defects, current T-cell booster therapy requires physicians to remove T-cells from the blood of a patient with cancer and inject the cells back into the patient after either genetically engineering or activating the cells in a laboratory so they recognize cancer-linked molecular flags.
One such treatment, called CAR-T therapy, is costly and available only at specialized centers with laboratories capable of the complicated task of engineering T-cells. In addition, it generally takes about six to eight weeks to culture the T-cells in laboratories and, once reintroduced into the body, the cells don’t last long in the patient’s body, so the effects of the treatment can be short-lived.
The new work, reported April 10 in the journal Advanced Materials, is a bid by Johns Hopkins scientists to find a more efficient way of engineering T-cells.
“We believe that a T-cell’s environment is very important. Biology doesn’t occur on plastic dishes; it happens in tissues,” says John Hickey, a Ph.D. candidate in biomedical engineering at the Johns Hopkins University School of Medicine and first author of the study report.
To make the engineered T-cells’ environment more biologically realistic, Hickey — working with his mentors Hai-Quan Mao, Ph.D., associate director of the Johns Hopkins Institute for NanoBioTechnology and Jonathan Schneck, M.D., Ph.D., professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine — tried using a jelly-like polymer, or hydrogel, as a platform for the T-cells. On the hydrogel, the scientists added two types of signals that stimulate and “teach” T-cells to hone in on foreign targets to destroy.
In their experiments, T-cells activated on hydrogels produced 50 percent more molecules called cytokines, a marker of activation, than T-cells kept on plastic culture dishes.
Because hydrogels can be made to order, the Johns Hopkins scientists created and tested a range of hydrogels, from the very soft feel of a single cell to the more rigid quality of a cell-packed lymph node.
“One of the surprising findings was that T-cells prefer a very soft environment, similar to interactions with individual cells, as opposed to a densely packed tissue,” says Schneck.
More than 80 percent of T-cells on the soft surface multiplied themselves, compared with none of the T-cells on the most firm type of hydrogel.
When the Johns Hopkins team put T-cells onto a soft hydrogel, they found that the T-cells multiplied from just a few cells to about 150,000 cells — plenty to use for cancer therapy — within seven days. By contrast, when the scientists used other conventional methods to stimulate and expand T-cells, they were able to culture only 20,000 cells within seven days.
In the next set of experiments, the scientists injected the T-cells engineered in either the soft hydrogels or the plastic culture dishes into mice implanted with melanoma, a lethal form of skin cancer. Tumors in mice with T-cells cultured on hydrogels remained stable in size, and some of the mice survived beyond 40 days. By contrast, tumors grew in most of the mice injected with T-cells cultured in plastic dishes, and none of these mice lived beyond 30 days.
“As we perfect the hydrogel and replicate the essential feature of the natural environment, including chemical growth factors that attract cancer-fighting T-cells and other signals, we will ultimately be able to design artificial lymph nodes for regenerative immunology-based therapy,” says Schneck, a member of the Johns Hopkins Kimmel Cancer Center.
The Latest on: Artificial lymph nodes
via Google News
The Latest on: Artificial lymph nodes
- Breast canceron September 9, 2020 at 2:58 am
One of them is inflammatory breast cancer where the cancer cells don’t cause tumour, but block lymph nodes near the breast. This leads to swelling. Other types of breast cancer may develop in ...
- Award for excellence in Alzheimer researchon September 8, 2020 at 2:34 am
Cellular waste products are transported into the blood via lymph vessels and nodes, degraded in the liver, and recycled or excreted in the urine. An exception to this is the brain, in which there are ...
- China Focus: Scientists develop AI model for quick cancer detectionon September 3, 2020 at 9:49 pm
Using artificial intelligence (AI) technologies, an international research team led by Chinese scientists has developed a rapid and accurate screening model to detect lymph nodes, which can assist ...
- Prostate Canceron September 1, 2020 at 5:00 pm
Artificial Intelligence can Diagnose Prostate ... This may reveal abnormally enlarged lymph nodes. Lymph nodes are a network of bean-sized collections of white blood cells that fight infection.
- How the Dutch resume elective surgery in melanoma after COVID delayson August 27, 2020 at 1:50 pm
The diagnostic tool, Merlin Assay, identifies melanoma (skin cancer) patients for whom postponing sentinel lymph node biopsy (SLNB) surgery would be at minimal risk, allowing physicians to better ...
- Pigs grow new liver in lymph nodes, study showson August 23, 2020 at 5:00 pm
Pigs grow new liver in lymph nodes, study shows Date: August 24, 2020 Source: University of Pittsburgh Summary: Hepatocytes -- the chief functional cells of the liver - are natural regenerators ...
- Turning Point: Policymaking in the Era of Artificial Intelligenceon August 7, 2020 at 12:48 pm
Artificial intelligence (AI ... imaging application to detect lymph nodes in the human body.¹ According to its developers, the key is labeling the nodes and identifying small lesions or growths that ...
- Radiotherapy can be used in hard-to-treat bladder canceron July 26, 2020 at 6:26 pm
More targeted forms of radiotherapy can effectively treat bladder cancer which has spread to the lymph nodes of the pelvis, according to a new clinical trial. This form of cancer – known as node ...
- Quantitative Assessment of the Effects of Compression on Deep Learning in Digital Pathology Image Analysison June 10, 2020 at 12:47 am
We investigated the effects of image compression on the performance of DL strategies in the context of 3 representative use cases involving segmentation of nuclei (n = 137), segmentation of lymph node ...
- High-precision radiotherapy can safely treat prostate cancer spreadon January 15, 2019 at 3:15 am
Credit: Annie Cavanagh. CC BY-NC 4.0 Men with ‘high risk’ prostate cancer can safely receive high-dose radiotherapy to kill cancer cells that have spread into neighbouring lymph nodes, a new study ...
via Bing News